Search Results - "Vana, Federica"

Antiangiogenic Therapy in Clear Cell Renal Carcinoma (CCRC): Pharmacological Basis and Clinical Results by Comandone, Alessandro, Vana, Federica, Comandone, Tiziana, Tucci, Marcello

“…Angiogenesis has a direct stimulatory effect on tumor growth, duplication, invasion and metastatic development. A significant portion of conventional renal…”
Get full text

The psychological impact of sarcoma on affected patients by Franzoi, Isabella Giulia, Granieri, Antonella, Sauta, Maria Domenica, Agnesone, Monica, Gonella, Marco, Grimaldi, Carola, Vallauri, Irene, Boglione, Antonella, Vana, Federica, Bergnolo, Paola, Comandone, Alessandro

“…Objective Sarcoma diagnosis and its treatment trajectory may deeply affect the somatopsychic balance of patients and their caregivers. This systematic review…”
Get full text

TEAM Study: Upfront Docetaxel Treatment in Patients With Metastatic Hormone-Sensitive Prostate Cancer: A Real-World, Multicenter, Retrospective Analysis by Pisano, Chiara, Turco, Fabio, Arnaudo, Elena, Fea, Elena, Vanella, Paola, Ruatta, Fiorella, Filippi, Roberto, Brusa, Federica, Prati, Veronica, Vana, Federica, Mennitto, Alessia, Cattrini, Carlo, Vignani, Francesca, Dionisio, Rossana, Icardi, Massimiliano, Guglielmini, Pamela, Buosi, Roberta, Stevani, Ilaria, Vormola, Roberto, Numico, Gianmauro, Depetris, Ilaria, Comandone, Alessandro, Gennari, Alessandra, Airoldi, Mario, Rossi, Maura, Vellani, Giorgio, Ortega, Cinzia, Tucci, Marcello, Maio, Massimo Di, Buttigliero, Consuelo

“…Treatment of metastatic hormone-sensitive prostate cancer (mHSPC) dramatically changed. PEACE-1 and ARASENS trials established triplet therapy efficacy…”
Get full text

The fat body mass increase after adjuvant androgen deprivation therapy is predictive of prostate cancer outcome by Buttigliero, Consuelo, Vana, Federica, Bertaglia, Valentina, Vignani, Francesca, Fiori, Cristian, Osella, Giangiacomo, Porpiglia, Francesco, Tucci, Marcello, Scagliotti, Giorgio Vittorio, Berruti, Alfredo

“…Androgen deprivation therapy (ADT) leads to important changes in body composition. No data are currently available about the relationship between these…”
Get full text

Chromogranin A expression in patients with hormone naïve prostate cancer predicts the development of hormone refractory disease by Berruti, Alfredo, Mosca, Alessandra, Porpiglia, Francesco, Bollito, Enrico, Tucci, Marcello, Vana, Federica, Cracco, Cecilia, Torta, Mirella, Russo, Lucianna, Cappia, Susanna, Saini, Andrea, Angeli, Alberto, Papotti, Mauro, Scarpa, Roberto Mario, Dogliotti, Luigi

“…We assessed chromogranin A as a tissue biomarker in prostate needle biopsies or as a plasma biomarker, a risk factor for hormone refractory prostate cancer. A…”
Get more information

Inferior mesenteric artery chemoembolization and chemotherapy for advanced rectal cancer: report of a clinical case by Bini, Roberto, Comelli, Simone, Addeo, Alfredo, Viora, Tiziana, Vana, Federica, Vaudano, Giacomo Paolo, Savio, Daniele, Leli, Renzo

“…Patients with advanced and incurable colorectal cancer have a very poor prognosis. Curative-intent resection was performed in 70%-90% of cases in reported…”
Get full text

Changes in bone mineral density after adjuvant aromatase inhibitors and fracture risk in breast cancer patients by Berruti, Alfredo, Tucci, Marcello, Mosca, Alessandra, Vana, Federica, Ardine, Mara, Dogliotti, Luigi, Angeli, Alberto, Bertoldo, Francesco

Get full text

Could the efficacy of docetaxel in prostate cancer patients be potentiated by concomitant high-dose calcitriol administration? by Berruti, Alfredo, Tucci, Marcello, Mosca, Alessandra, Ardine, Mara, Poggio, Massimiliano, Saini, Andrea, Russo, Lucianna, Vana, Federica, Dogliotti, Luigi

Get full text